Johnson & Johnson (NYSE: JNJ) remains a steadfast giant in the healthcare sector, known for its broad array of products spanning from pharmaceuticals to medical devices. As the company operates..
AstraZeneca PLC (NYSE: AZN), a global leader in the biopharmaceutical realm, continues to capture investor attention with its robust portfolio and promising financial outlook. With a current market capitalization of..
Investors with a focus on the healthcare sector, particularly those interested in pioneering pharmaceutical innovations, should keep a close eye on Neurocrine Biosciences, Inc. (NBIX). This San Diego-based company, with..
Cencora, Inc. (NYSE: COR), a leading player in the medical distribution industry, stands out in the healthcare sector with a market capitalization of $68.08 billion. Formerly known as AmerisourceBergen, Cencora’s..
Bio-Techne Corp (NASDAQ: TECH), a key player in the healthcare sector with a focus on biotechnology, presents an intriguing opportunity for investors with its substantial potential upside. With a market..
As the demand for healthcare solutions continues to escalate globally, STERIS plc (NYSE: STE) stands out as a formidable player in the medical devices industry. With a robust market capitalization..
ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, is attracting investor attention with its potential 28.6% upside based on current analyst ratings. Operating within the medical instruments..
Bristol-Myers Squibb Company (NYSE: BMY), a giant in the healthcare sector, has long been a cornerstone in the biopharmaceutical industry, delivering innovative treatments across oncology, hematology, immunology, and cardiovascular diseases...
Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, specializes in diagnostics and research, offering an extensive suite of clinical development services. With a market capitalization of..
Universal Health Services, Inc. (NYSE: UHS) is drawing investor attention with its impressive potential upside of 29.28%, based on the current stock price of $192.42 and an average analyst target..
Moderna, Inc. (NASDAQ: MRNA) stands as a formidable player in the biotechnology sector, primarily recognized for its pioneering work in mRNA medicines. As the company navigates the complexities of a..
In the dynamic world of biopharmaceuticals, United Therapeutics Corporation (NASDAQ: UTHR) continues to make waves with its innovative approach to treating chronic and life-threatening diseases. As a leading player in..
For investors seeking opportunities in the healthcare sector, AbbVie Inc. (NYSE: ABBV) stands out as a formidable player with a robust portfolio of pharmaceutical products and therapies. With a market..
HealthEquity, Inc. (NASDAQ: HQY) stands at a compelling juncture for investors, offering a significant potential upside of 47.07%, underpinned by a strong consensus among analysts. As a leader in the..
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, is capturing investor attention with its compelling growth trajectory and promising market positioning. With a current market capitalization..
Haleon plc (HLN), a prominent player in the healthcare sector, has recently captured investor attention with its potential upside of 18.92%. While the company’s roots trace back to 1715, its..
Gilead Sciences, Inc. (NASDAQ: GILD), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and strategic advancements in the biopharmaceutical landscape. With a..
BeOne Medicines Ltd. (ONC), a notable player in the biotechnology sector, is capturing investor attention with its robust growth prospects and promising target price range. Headquartered in Basel, Switzerland, BeOne..
Investors have their eyes on The Cooper Companies, Inc. (NYSE: COO) as it continues to present intriguing opportunities within the healthcare sector. Specializing in medical instruments and supplies, Cooper Companies..
ICON plc (NASDAQ: ICLR) has caught the attention of investors with a potentially substantial upside of 41%, according to the latest analyst ratings. As a leader in the healthcare sector,..
